Domark International (DOMK) 10-Q 14 Apr 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Feb. 29, 2016shares
Document And Entity Information
Entity Registrant Name	Domark International Inc.
Entity Central Index Key	1,365,160
Document Type	10-Q
Document Period End Date	Feb. 29, 2016
Amendment Flag	false
Current Fiscal Year End Date	--05-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	34,119,605
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,016

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Feb. 29, 2016	May. 31, 2015
CURRENT ASSETS
Cash and cash equivalents
Loan receivable from consultant		$ 36,203
Prepaid expenses		4,500
TOTAL CURRENT ASSETS		40,703
INVESTMENTS	$ 1,144,166	1,144,166
OTHER ASSETS
Patents, net of accumulated amortization of $21,105 and $13,605, respectively	49,397	56,897
Licenses, net of accumulated amortization of $305,418 and $268,338 respectively	4,582	41,662
TOTAL OTHER ASSETS	53,979	98,559
TOTAL ASSETS	1,198,145	1,283,428
CURRENT LIABILITIES
Amounts payable to Bank	22	115
Note payable to bank	198,000	198,000
Accounts payable and accrued expenses	225,767	855,665
Amounts due under Licensing Agreement with Wazzamba SA	224,924	224,924
Loans payable to consultants and stockholders	126,993	189,928
Convertible notes payable (net of unamortized discounts of $7 and $674,886 respectively)	759,276	580,956
Derivative liability for convertible notes payable	3,516,450	2,564,280
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	5,051,432	4,613,868
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares as of February 29, 2016 and May 31, 2015	50	$ 50
Preferred stock, $0.001 par value, authorized 2,000,000 shares: Series B convertible preferred stock - issued and outstanding 1,950,000 shares as of February 29, 2016 and "0" as of May 31, 2015	1,950
Common stock, $0.001 par value, authorized 30,000,000 shares: 8,765,022 and 8,805,932,169 shares issued, and 8,765,022 and 8,681,112,367 shares outstanding, as of February 29, 2016 and May 31, 2015	8,765	$ 8,805,932
Less: Treasury stock 20,803 shares as of February 29, 2016 and 124,819,802 as of May 31, 2015	(21)	(124,820)
Common stock payable	858,000	858,000
Additional paid-in capital	46,494,400	36,219,642
Accumulated other comprehensive income (loss)	(131,453)	(126,453)
Accumulated deficit	(51,084,978)	(48,962,791)
TOTAL STOCKHOLDERS' DEFICIT	(3,853,287)	(3,330,440)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,198,145	$ 1,283,428

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Feb. 29, 2016	May. 31, 2015
OTHER ASSETS
Patents, net of accumulated amortization	$ 21,105	$ 13,605
License, net of accumulated amortization	305,418	268,338
CURRENT LIABILITIES
Convertible notes payable net of unamortized discounts	$ 7	$ 674,886
STOCKHOLDERS' DEFICIT
Preferred stock series A, par value	$ 0.001	$ 0.001
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Convertible preferred stock series B, par value	0.001	0.001
Convertible preferred stock series B, shares authorized	2,000,000	2,000,000
Convertible preferred stock series B, shares issued	1,950,000	0
Convertible preferred stock series B, shares outstanding	1,950,000	0
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	30,000,000	30,000,000
Common Stock, shares issued	8,765,022	8,805,932,169
Common Stock, shares outstanding	8,765,022	8,681,112,367
Treasury Stock, Shares	20,803	124,819,802

Consolidated Statement Of Opera

Consolidated Statement Of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 29, 2016	Feb. 28, 2015	Feb. 29, 2016	Feb. 28, 2015
Consolidated Statement Of Operations
Sales
Cost of sales
Gross profit
Operating expenses:
General and administrative	$ (658,858)	$ 27,563	$ (417,052)	$ 269,369
Stock-based compensation - consultants	$ 1,270,380	$ 24,003	$ 1,326,000	$ 79,623
Stock-based compensation - Salaries and wages
Depreciation and amortization expense	$ (62,140)	$ 55,360	$ 44,580	$ 162,080
Total operating expenses	549,382	106,926	953,528	511,072
Loss from operations	$ (549,382)	$ (106,926)	$ (953,528)	$ (511,072)
Other income (expense):
Other income
Revaluation of derivative liability for convertible notes	$ (284,989)	$ 101,879	$ (952,170)	$ (565,302)
Interest expense	122,741	(441,262)	(221,489)	(785,492)
Total other income (expense)	(162,248)	(339,383)	(1,173,659)	(1,350,794)
Net Loss	(711,630)	(446,309)	(2,127,187)	(1,861,866)
Statement of Comprehensive Income: Net income (loss)	(711,630)	(446,309)	(2,127,187)	(1,861,866)
Other Comprehensive Loss
Foreign currency adjustment	18,689	(14,213)	(5,000)	(37,902)
Total Other Comprehensive Loss	18,689	(14,213)	(5,000)	(37,902)
Total comprehensive loss	$ (692,941)	$ (460,522)	$ (2,132,187)	$ (1,899,768)
Net loss per common shares, basic and diluted	$ 0.29	$ 0	$ (0.27)	$ 0
Weighted average common shares outstanding	8,455,999	7,743,117,000	7,775,110	6,582,115,000

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (2,127,187)	$ (1,861,866)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	44,580	162,080
Common stock issued as compensation - consultants	$ 1,326,000	$ 79,623
Common stock issued as compensation
Non cash interest expense	$ 221,489	$ 785,492
Loss (gain) on derivative valuation	952,170	$ 565,302
Effect of reverse stock split	177,106
Changes in operating assets and liabilities:
Prepaid expenses	(40,703)
Accounts payable and accrued expenses	(629,895)	$ (4,830)
Accounts payable - related party	(62,935)	7,644
Net cash used in operating activities	$ (139,375)	$ (266,555)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments
Cash paid for loan receivable from consultant
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	$ 144,375	$ 180,829
Proceeds from loans payable to consultants and stockholders		$ 123,103
Payments made on loans payables to consultants & stockholders
Net cash provided by financing activities	$ 144,375	$ 303,932
Other Comprehensive income (loss) effect of exchange rate changes on cash	(5,000)	(37,902)
Net increase (decrease) in cash and cash equivalents	0	(525)
CASH BALANCE BEGINNING OF PERIOD	(22)	460
CASH BALANCE END OF PERIOD	(22)	(65)
Cash paid for interest	0	20,424
Cash paid for taxes	$ 0	0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Shares issued for settlement of loans payable to consultants and stockholders		65,102
Shares issued for settlement of convertible notes payable	$ 27,197	$ 487,998

Description of Business

Description of Business	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 1 - Description of Business	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement. On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company's subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification ("ASC") Topic Nos, 860-20-25 and 860-20-40 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold. On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State. On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State. On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company's corporate operations based in Toronto, Ontario, Canada. On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. ("Zaktek"). Zaktek's main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhoneÒ and Samsung Galaxy products to improve functionality including video and gaming abilities. On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark. On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going Concern

Going Concern	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 2 - Going Concern	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors, promissory notes from lenders, and the support of certain stockholders. These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There isn't any assurance that the Company will be successful in raising additional capital to meet its operating needs.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 3 - Basis of Presentation	The unaudited consolidated financial statements as of February 29, 2016 and for the nine months ended February 28, 2015 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of February 29, 2016 and the results of operations and cash flows for the nine months ended February 29, 2016 and February 28, 2015. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the nine month period February 29, 2016 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2016. The consolidated balance sheet at February 29, 2016 has been derived from the unaudited consolidated financial statements at that date.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 4 - Summary of Significant Accounting Policies	RECENT ACCOUNTNG PRONOUNCEMENTS In June 2014, The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities (Topic PRINCIPLES OF CONSOLIDATION The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3. Foreign Currency Translation and Transaction Gains and Losses We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders' deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rate as of February 29, 2016 was $.75 US equaled $1.00 Canadian. USE OF ESTIMATES The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates. The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable. CASH AND CASH EQUIVALENTS The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At February 29, 2016 there weren't any cash or cash equivalents. At February 29, 2016 and May 31, 2015, cash and cash equivalents consisted only of cash in the bank, or a bank over draft. LOANS RECEIVABLE CONSULTANT The loan receivable consultants are a short term, less than one-year note, due September 30, 2016 and non-interest bearing. NET LOSS PER COMMON SHARE Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation. For the nine months ending February 29, 2016 and February 28, 2015, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive: Serie A Convertible Preferred Shares 50,000,000 50,000,000 Serie B Convertible Preferred Shares 15,600,000,000 - Warrants 850,000 850,000 Total Common Share Equivalents 15,942,795,445 2,712,570,333 INTANGIBLE ASSETS Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets. IMPAIRMENT OF LONG-LIVED ASSETS In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. STOCK-BASED COMPENSATION The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as stock volatility, interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued free trading shares from the Company's authorized common stock. ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505. RESEARCH AND DEVELOPMENT All research and development expenditures are expensed as incurred. REVENUE RECOGNITION The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured. In the nine month periods ending February 29, 2016 and February 28, 2015 there weren't any revenues.

Investments

Investments	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 5 - Investments	Investments consist of: February 29, February 28, 2016 2015 Imagic Ltd. - 40% equity interest $ 1,094,166 $ 1,094,166 Barefoot Science Products & Services Inc. - 15% equity interest 50,000 50,000 Total $ 1,144,166 $ 1,144,166 The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of: July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $ 697,500 December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd. 96,005 Cash payments to or for the benefit of Imagic Ltd. 150,661 Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings 150,000 Total $ 1,094,166 Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended November 30, 2015.

Licensing Agreement With Wazzam

Licensing Agreement With Wazzamba Sa	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 6 - Licensing Agreement With Wazzamba Sa	During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the "Licensor"). The agreement provides the Company an exclusive license to use certain technology (which permits third-party subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor "Flat Fee" compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus "Revenue Share" compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party. At November 30, 2015, the Company has a recorded intangible asset for "Licensing Agreement with Wazzamba SA" in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month). On March 27, 2014, the Company paid $75,000 of the first $300,000 "Flat Fee" installment due the Licensor under the agreement. The other $225,000 due is presently past due. Licenses, net of accumulated amortization are as follows: February 29, May 31, 2016 2015 Wazzamba S.A. $ 300,000 $ 300,000 Bioharmonics 10,000 10,000 Subtotal 310,000 310,000 Accumulated amortization (305,418 ) (268,338 ) Totals $ 4,582 $ 41,662

Note Payable To Bank

Note Payable To Bank	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 7 - Note Payable To Bank	In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 2,500,000 shares of Domark International, Inc (Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company's chief financial officer and his wife, and certain real property owned by the Company's chief financial officer and his wife. The loan has been modified and the lender has extended a twelve month extension for the loan repayment, with a December 31, 2016 balloon due date.

Loans Payable to Consultants an

Loans Payable to Consultants and Stockholders	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 8 - Loans Payable To Related Parties, Consultants, And Stockholders	Loans payable to consultants and stockholders consist of ; February 29, May 31, 2016 2015 Consultant and stockholder $ 80,796 $ 90,402 President of Domark - 47,500 Non-exec Chairman of Domark - 11,875 Chairman of BarefoOT Science and affilliate 21,500 21,500 Consultant 16,097 16,097 Consultant 8,600 2,554 Totals $ 126,993 $ 189,928 These loans are informal and do not provide for interest or a stated maturity date.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 9 - Convertible Notes Payable	At February 29, 2016 the convertible notes payable consisted of ; Date of Note Noteholder Interest Rate Maturity Date Principal Amount Unamortized Discount Net Note 12/19/13 JMJ Financial Inc 10 % 12/19/14 $ 26,557 (i) $ 0 $ 26,557 3/7/14 JSJ Investments, Inc. 12 % 10/7/14 11,886 (g) 0 11,886 3/28/14 Redwood Fund III 10 % 9/28/14 35,122 (f) 0 35,122 3/18/14 Redwood Managament, LLC. 10 % 9/28/14 50,000 (g) 0 50,000 4/14/14 WHC Capital, Inc 12 % 10/14/14 37,830 (i) 0 37,830 4/11/14 Tonaquint, Inc 12 % 10/11/14 39,681 (g) 0 39,681 4/24/14 JSJ Investments, Inc. 12 % 10/24/14 50,000 (g) 0 50,000 5/12/14 Iconic Holdings, LLC 10 % 11/12/14 46,356 (g) 0 46,356 5/16/14 KBM Worldwide, Inc 8 % 11/14/14 11,240 (l) 0 11,240 6/3/14 Adar Bays, Inc 8 % 12/12/14 48,654 (g) 0 48,654 6/23/14 JMJ Financial Inc 10 % 12/23/14 50,000 (i) 0 50,000 7/3/14 LG Capital, Inc 8 % 1/3/15 35,000 (a) 0 35,000 7/22/14 Redwood Fund III 10 % 1/22/15 100,082 (g) 0 100,082 8/14/14 KBM Worldwide, Inc 8 % 2/14/15 27,500 (l) 0 27,500 10/8/14 LG Capital, Inc 8 % 4/8/15 3,000 (a) 0 3,000 12/2/14 Tonaquint, Inc 12 % 6/2/15 10,000 (g) 0 10,000 12/5/14 LG Capital, Inc. 8 % 6/5/15 9,500 (a) 0 9,500 1/7/15 LG Capital Inc 8 % 7/7/15 22,500 (a) 0 22,500 7/22/15 LG Capital Inc 8 % 1/22/15 60,375 (a) 7 60,368 7/22/15 JMJ Financial Inc 10 % 1/22/15 20,000 (i) 0 20,000 7/17/15 Iconic Holdings, LLC 10 % 1/17/15 22,000 (g) 0 22,000 7/22/15 Redwood Fund III 10 % 1/22/15 22,000 (g) 0 22,000 7/18/15 Tonaquint, Inc 12 % 1/18/15 20,000 (g) 0 20,000 Totals $ 759,283 $ 7 $ 759,276 Legend (a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion. (b) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion. (c) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion. (d) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion. (e) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion. (f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion. (g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion. (h) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion. (i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion. (j) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion. (k) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion. (l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders Equity

Stockholders Equity	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 10 - Stockholders' Equity	Series A Convertible Preferred Stock Each share of Series A Convertible Preferred Stock has .67 share voting rights and is convertible into .67 shares of the Company's common stock. Series B Convertible Preferred Stock Each share of Series B Convertible Preferred Stock has 1,333 voting rights and is convertible into 1,333 shares of the Company's common stock. Common Stock Issuances On January 22, 2016, the Company issued 192,667 shares of common shares on behalf of Iconic Holdings LLC. in satisfaction of $289 unpaid debt. On January 29, 2016, the Company issued 5,000,000 common shares on behalf of Curran in satisfaction of $25,000 of unpaid debt. On February 25, 2016, the Company issued 1,526,728 common shares on behalf of LG Capital, Inc. in satisfaction of $1,908 of unpaid debt. Warrants to Purchase Common Stock A summary of warrant activity from May 31, 2012 until the nine months ending February 29, 2016 are as follows: Weighted Average Number of Exercise Warrants Price Outstanding at May 31, 2012 - $ - Granted 850,000 0.42 Exercised - - Cancelled - - Outstanding at May 31, 2013 850,000 0.42 Granted - - Exercised - - Cancelled - - Outstanding at February 29, 2016 850,000 $ 0.42 Warrants outstanding at February 29, 2016 consist of: Date Granted Number Outstanding Exercise price Expiration Date May 25, 2012 100,000 $ 1.00 May 25, 2016 June 12, 2012 150,000 $ 1.00 June 12, 2016 June 26, 2012 100,000 $ 1.00 June 26, 2016 January 1, 2012 500,000 $ 0.01 January 1, 2016 Totals 850,000

Fair Value Measurements and Der

Fair Value Measurements and Derivative Liabiliity	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 11 - Fair Value Measurements and Derivative Liabiliity	The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting ate, with changes in the fair value reported as charges or credits to income. For option-based derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. During the period ended February 29, 2016 the Company entered into $144,375 of convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance. Under ASC-815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement. As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management's best estimate of fair value. Derivative liability — the Company's derivative liability is classified within Level 3 of the fair value hierarchy. The Company uses the Black Scholes Option Pricing Model to value its option based derivatives predicated upon the following assumptions: dividend yield of -0-%, volatility of stock price =200%, risk free interest rate varying from 8 to 12% and an expected term equal to the remaining conversion period of the note. The following table sets forth by level within the fair value hierarchy the Company's financial assets and liabilities that were accounted for at fair value as of February 29, 2016. Recurring Fair Value Measurements Level 1 Level 2 Level 3 Total LIABILITIES: Derivative liability- February 29, 2016 - - 3,516,450 3,516,450 Derivative liability- May 31, 2015 - - 2,564,280 2,564,280

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 12 - Commitments and Contingencies	License Agreements On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018. On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. ("Bioharmoniecs"). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging. In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6. Employment Agreements On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.

Subsequent Event

Subsequent Event	9 Months Ended
	Feb. 29, 2016
Notes to Financial Statements
Note 13 - Subsequent Event	In September 22, 2015 the Company applied to FINRA to enact a 1:6000 (one for six thousand) one common share for six thousand common shares, reverse stock split. The Company already had the form 14C approved by the SEC to apply for the reverse stock split. Since there are two shareholders with over 63% (sixty three per cent) voting control, there wasn't any need for a proxy vote on the reverse stock split. The Company's ahareholder's were notified of the reverse stock split application, Due to the fact the Company's stock value was significantly low, the Company needed to do a reverse stock split to raise potential capital , through promissory note and investment vehicle funding, to continue operations. Mr. Andrew Ritchie, is still the Company's CEO, President, and sole board director. The Company is actively seeking a sale, joint venture, marketing partnership, or any other related venture opportunity with Simba Deals.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Feb. 29, 2016
Summary Of Significant Accounting Policies Policies
Recent Accountng Pronouncements	In June 2014, The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation" ("ASU 2014-10"). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended February 29, 2016 and year ended May 31, 2015. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Principles of Consolidation	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3.
Foreign Currency Translation and Transaction Gains and Losses	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders' deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rate as of February 29, 2016 was $.75 US equaled $1.00 Canadian.
Use of Estimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates. The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At February 29, 2016 there weren't any cash or cash equivalents. At February 29, 2016 and May 31, 2015, cash and cash equivalents consisted only of cash in the bank, or a bank over draft.
Loan Receivable Consultant	The loan receivable consultants are a short term, less than one-year note, due September 30, 2016 and non-interest bearing.
Net Loss Per Common Share	Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation. For the nine months ending February 29, 2016 and February 28, 2015, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive: Serie A Convertible Preferred Shares 50,000,000 50,000,000 Serie B Convertible Preferred Shares 15,600,000,000 - Warrants 850,000 850,000 Total Common Share Equivalents 15,942,795,445 2,712,570,333
Intangible Assets	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Impairment of Long-Lived Assets	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock-Based Compensation	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as stock volatility, interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued free trading shares from the Company's authorized common stock. ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Research and Development	All research and development expenditures are expensed as incurred.
Revenue Recognition	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured. In the nine month periods ending February 29, 2016 and February 28, 2015 there weren't any revenues.

Summary of Significant Accoun20

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Feb. 29, 2016
Summary Of Significant Accounting Policies Tables
Net Loss Per Common Share	Serie A Convertible Preferred Shares 50,000,000 50,000,000 Serie B Convertible Preferred Shares 15,600,000,000 - Warrants 850,000 850,000 Total Common Share Equivalents 15,942,795,445 2,712,570,333

Investments (Tables)

Investments (Tables)	9 Months Ended
	Feb. 29, 2016
Investments Tables
Investments	February 29, February 28, 2016 2015 Imagic Ltd. - 40% equity interest $ 1,094,166 $ 1,094,166 Barefoot Science Products & Services Inc. - 15% equity interest 50,000 50,000 Total $ 1,144,166 $ 1,144,166
Cost of equity interest 40%	July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $ 697,500 December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd. 96,005 Cash payments to or for the benefit of Imagic Ltd. 150,661 Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings 150,000 Total $ 1,094,166

Licensing Agreement With Wazz22

Licensing Agreement With Wazzamba Sa (Tables)	9 Months Ended
	Feb. 29, 2016
Licensing Agreement With Wazzamba Sa Tables
Licenses, net of accumulated amortization	February 29, May 31, 2016 2015 Wazzamba S.A. $ 300,000 $ 300,000 Bioharmonics 10,000 10,000 Subtotal 310,000 310,000 Accumulated amortization (305,418 ) (268,338 ) Totals $ 4,582 $ 41,662

Loans Payable to Consultants 23

Loans Payable to Consultants and Stockholders (Tables)	9 Months Ended
	Feb. 29, 2016
Loans Payable To Consultants And Stockholders Tables
Loans payable to related parties, consultants, and stockholders	February 29, May 31, 2016 2015 Consultant and stockholder $ 80,796 $ 90,402 President of Domark - 47,500 Non-exec Chairman of Domark - 11,875 Chairman of BarefoOT Science and affilliate 21,500 21,500 Consultant 16,097 16,097 Consultant 8,600 2,554 Totals $ 126,993 $ 189,928

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Feb. 29, 2016
Convertible Notes Payable Tables
Convertible notes payable	At February 29, 2016 the convertible notes payable consisted of ; Date of Note Noteholder Interest Rate Maturity Date Principal Amount Unamortized Discount Net Note 12/19/13 JMJ Financial Inc 10 % 12/19/14 $ 26,557 (i) $ 0 $ 26,557 3/7/14 JSJ Investments, Inc. 12 % 10/7/14 11,886 (g) 0 11,886 3/28/14 Redwood Fund III 10 % 9/28/14 35,122 (f) 0 35,122 3/18/14 Redwood Managament, LLC. 10 % 9/28/14 50,000 (g) 0 50,000 4/14/14 WHC Capital, Inc 12 % 10/14/14 37,830 (i) 0 37,830 4/11/14 Tonaquint, Inc 12 % 10/11/14 39,681 (g) 0 39,681 4/24/14 JSJ Investments, Inc. 12 % 10/24/14 50,000 (g) 0 50,000 5/12/14 Iconic Holdings, LLC 10 % 11/12/14 46,356 (g) 0 46,356 5/16/14 KBM Worldwide, Inc 8 % 11/14/14 11,240 (l) 0 11,240 6/3/14 Adar Bays, Inc 8 % 12/12/14 48,654 (g) 0 48,654 6/23/14 JMJ Financial Inc 10 % 12/23/14 50,000 (i) 0 50,000 7/3/14 LG Capital, Inc 8 % 1/3/15 35,000 (a) 0 35,000 7/22/14 Redwood Fund III 10 % 1/22/15 100,082 (g) 0 100,082 8/14/14 KBM Worldwide, Inc 8 % 2/14/15 27,500 (l) 0 27,500 10/8/14 LG Capital, Inc 8 % 4/8/15 3,000 (a) 0 3,000 12/2/14 Tonaquint, Inc 12 % 6/2/15 10,000 (g) 0 10,000 12/5/14 LG Capital, Inc. 8 % 6/5/15 9,500 (a) 0 9,500 1/7/15 LG Capital Inc 8 % 7/7/15 22,500 (a) 0 22,500 7/22/15 LG Capital Inc 8 % 1/22/15 60,375 (a) 7 60,368 7/22/15 JMJ Financial Inc 10 % 1/22/15 20,000 (i) 0 20,000 7/17/15 Iconic Holdings, LLC 10 % 1/17/15 22,000 (g) 0 22,000 7/22/15 Redwood Fund III 10 % 1/22/15 22,000 (g) 0 22,000 7/18/15 Tonaquint, Inc 12 % 1/18/15 20,000 (g) 0 20,000 Totals $ 759,283 $ 7 $ 759,276

Stockholders Equity (Tables)

Stockholders Equity (Tables)	9 Months Ended
	Feb. 29, 2016
Stockholders Equity Tables
Summary of warrant activity	Weighted Average Number of Exercise Warrants Price Outstanding at May 31, 2012 - $ - Granted 850,000 0.42 Exercised - - Cancelled - - Outstanding at May 31, 2013 850,000 0.42 Granted - - Exercised - - Cancelled - - Outstanding at February 29, 2016 850,000 $ 0.42
Warrants outstanding	Date Granted Number Outstanding Exercise price Expiration Date May 25, 2012 100,000 $ 1.00 May 25, 2016 June 12, 2012 150,000 $ 1.00 June 12, 2016 June 26, 2012 100,000 $ 1.00 June 26, 2016 January 1, 2012 500,000 $ 0.01 January 1, 2016 Totals 850,000

Fair Value Measurements and D26

Fair Value Measurements and Derivative Liabiliity (Tables)	9 Months Ended
	Feb. 29, 2016
Fair Value Measurements And Derivative Liabiliity Tables
Recurring Fair Value Measurements	Recurring Fair Value Measurements Level 1 Level 2 Level 3 Total LIABILITIES: Derivative liability- February 29, 2016 - - 3,516,450 3,516,450 Derivative liability- May 31, 2015 - - 2,564,280 2,564,280

Summary of Significant Accoun27

Summary of Significant Accounting Policies (Details) - shares	9 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Summary Of Significant Accounting Policies Details
Series A convertible preferred shares	50,000,000	50,000,000
Series B convertible preferred shares	15,600,000,000
Warrants	850,000	850,000
Total common shares equivalent	15,942,795,445	2,712,570,333

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Details Narrative)	Feb. 29, 2016
Summary Of Significant Accounting Policies Details Narrative
Foreign currency translation rates US	0.75
Foreign currency translation rates Canadian	1

Investments (Details)

Investments (Details) - USD ($)	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2014
Investments Details
Imagic Ltd. - 40% equity interest	$ 1,094,166	$ 1,094,166	$ 1,094,166
Barefoot Science Products & Services Inc. - 15% equity interest	50,000	50,000
Total	$ 1,144,166	$ 1,144,166

Investments (Details 1)

Investments (Details 1) - USD ($)	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2014
Investments Details
July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.			697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.			96,005
Cash payments to or for the benefit of Imagic Ltd.			$ 150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings			150,000
Total	$ 1,094,166	$ 1,094,166	$ 1,094,166

Licensing Agreement With Wazz31

Licensing Agreement With Wazzamba Sa (Details) - USD ($)	Feb. 29, 2016	May. 31, 2015
Licensing Agreement With Wazzamba Sa Details
Wazzamba, S.A.	$ 300,000	$ 300,000
Bioharmonics	10,000	10,000
Subtotal	310,000	310,000
Accumulated amortization	(305,418)	(268,338)
Totals	$ 4,582	$ 41,662

Loans Payable to Consultants 32

Loans Payable to Consultants and Stockholders (Details) - USD ($)	Feb. 29, 2016	May. 31, 2015
Loans payable to consultants and stockholders	$ 126,993	$ 189,928
Consultant And Stockholder [Member]
Loans payable to consultants and stockholders	$ 80,796	90,402
President of Domark [Member]
Loans payable to consultants and stockholders		47,500
Non-exec Chairman of Domark [Member]
Loans payable to consultants and stockholders		11,875
Chairman Of Barefor Science And Affiliate [Member]
Loans payable to consultants and stockholders	$ 21,500	21,500
Consultant [Member]
Loans payable to consultants and stockholders	16,097	16,097
Consultant One [Member]
Loans payable to consultants and stockholders	$ 8,600	$ 2,554

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)		9 Months Ended
		Feb. 29, 2016	May. 31, 2015
Principal Amount		$ 759,283
Unamortized Discount		7	$ 674,886
Net Note		$ 759,276	$ 580,956
JMJ Financial Inc. [Member]
Date of Note		Dec. 19, 2013
Interest Rate		10.00%
Maturity date		Dec. 19, 2014
Principal Amount	[1]	$ 26,557
Unamortized Discount		0
Net Note		$ 26,557
JSJ Investments, Inc [Member]
Date of Note		Mar. 7, 2014
Interest Rate		12.00%
Maturity date		Oct. 7, 2014
Principal Amount	[2]	$ 11,886
Unamortized Discount		0
Net Note		$ 11,886
Redwood Fund, III [Member]
Date of Note		Mar. 28, 2014
Interest Rate		10.00%
Maturity date		Sep. 28, 2014
Principal Amount	[3]	$ 35,122
Unamortized Discount		0
Net Note		$ 35,122
Redwood Management, LLC [Member]
Date of Note		Mar. 18, 2014
Interest Rate		10.00%
Maturity date		Sep. 28, 2014
Principal Amount	[2]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
WHC Capital, Inc [Member]
Date of Note		Apr. 14, 2014
Interest Rate		12.00%
Maturity date		Oct. 14, 2014
Principal Amount	[1]	$ 37,830
Unamortized Discount		0
Net Note		$ 37,830
Tonaquint Inc [Member]
Date of Note		Apr. 11, 2014
Interest Rate		12.00%
Maturity date		Oct. 11, 2014
Principal Amount	[2]	$ 39,681
Unamortized Discount		0
Net Note		$ 39,681
JSJ Investments, Inc One [Member]
Date of Note		Apr. 24, 2014
Interest Rate		12.00%
Maturity date		Oct. 24, 2014
Principal Amount	[2]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
Iconic Holdings, LLC [Member]
Date of Note		May 12, 2014
Interest Rate		10.00%
Maturity date		Nov. 12, 2014
Principal Amount	[2]	$ 46,356
Unamortized Discount		0
Net Note		$ 46,356
KBM Worldwide, Inc [Member]
Date of Note		May 16, 2014
Interest Rate		8.00%
Maturity date		Nov. 14, 2014
Principal Amount	[4]	$ 11,240
Unamortized Discount		0
Net Note		$ 11,240
Adar Bays, Inc [Member]
Date of Note		Jun. 3, 2014
Interest Rate		8.00%
Maturity date		Dec. 12, 2014
Principal Amount	[2]	$ 48,654
Unamortized Discount		0
Net Note		$ 48,654
JMJ Financial, Inc One [Member]
Date of Note		Jun. 23, 2014
Interest Rate		10.00%
Maturity date		Dec. 23, 2014
Principal Amount	[1]	$ 50,000
Unamortized Discount		0
Net Note		$ 50,000
LG Capital, Inc [Member]
Date of Note		Jul. 3, 2014
Interest Rate		8.00%
Maturity date		Jan. 3, 2015
Principal Amount	[5]	$ 35,000
Unamortized Discount		0
Net Note		$ 35,000
Redwood Fund, III One [Member]
Date of Note		Jul. 22, 2014
Interest Rate		10.00%
Maturity date		Jan. 22, 2015
Principal Amount	[2]	$ 100,082
Unamortized Discount		0
Net Note		$ 100,082
KBM Worldwide, Inc One [Member]
Date of Note		Aug. 14, 2014
Interest Rate		8.00%
Maturity date		Feb. 14, 2015
Principal Amount	[4]	$ 27,500
Unamortized Discount		0
Net Note		$ 27,500
LG Capital, Inc One [Member]
Date of Note		Oct. 8, 2014
Interest Rate		8.00%
Maturity date		Apr. 8, 2015
Principal Amount	[5]	$ 3,000
Unamortized Discount		0
Net Note		$ 3,000
Tonaquint, Inc One [Member]
Date of Note		Dec. 2, 2014
Interest Rate		12.00%
Maturity date		Jun. 2, 2015
Principal Amount	[2]	$ 10,000
Unamortized Discount		0
Net Note		$ 10,000
LG Capital, Inc. Two [Member]
Date of Note		Dec. 5, 2014
Interest Rate		8.00%
Maturity date		Jun. 5, 2015
Principal Amount	[5]	$ 9,500
Unamortized Discount		0
Net Note		$ 9,500
LG Capital, Inc. Three [Member]
Date of Note		Jan. 7, 2015
Interest Rate		8.00%
Maturity date		Jul. 7, 2015
Principal Amount	[5]	$ 22,500
Unamortized Discount		0
Net Note		$ 22,500
LG Capital Inc Four [Member]
Date of Note		Jul. 22, 2015
Interest Rate		8.00%
Maturity date		Jan. 22, 2015
Principal Amount	[5]	$ 60,375
Unamortized Discount		7
Net Note		$ 60,368
JMJ Financial, Inc Two [Member]
Date of Note		Jul. 22, 2015
Interest Rate		10.00%
Maturity date		Jan. 22, 2015
Principal Amount	[1]	$ 20,000
Unamortized Discount		0
Net Note		$ 20,000
Iconic Holdings, LLC One [Member]
Date of Note		Jul. 17, 2015
Interest Rate		10.00%
Maturity date		Jan. 17, 2015
Principal Amount	[2]	$ 22,000
Unamortized Discount		0
Net Note		$ 22,000
Redwood Fund, III Two [Member]
Date of Note		Jul. 22, 2015
Interest Rate		10.00%
Maturity date		Jan. 22, 2015
Principal Amount	[2]	$ 22,000
Unamortized Discount		0
Net Note		$ 22,000
Tonaquint, Inc Two [Member]
Date of Note		Jul. 18, 2015
Interest Rate		12.00%
Maturity date		Jan. 18, 2015
Principal Amount	[2]	$ 20,000
Unamortized Discount		0
Net Note		$ 20,000
[1]	(i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
[2]	(g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
[3]	(f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
[4]	(l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
[5]	(a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.

Stockholders' Equity (Details)

Stockholders' Equity (Details) - $ / shares	12 Months Ended	33 Months Ended
	May. 31, 2013	Feb. 29, 2016
Stockholders Equity Details
Outstanding Number of Warrants, Beginning Balance		850,000
Granted	850,000
Exercised
Cancelled
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance		$ 0.42
Granted	$ 0.42
Exercised
Cancelled
Weighted Average Exercise Price, Ending Balance	$ 0.42	$ 0.42

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1) - $ / shares	9 Months Ended
	Feb. 29, 2016	May. 31, 2013	May. 31, 2012
Number Of Warrant Outstanding	850,000	850,000
Warrant [Member]
Date Granted	May 25, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1
Expiration Date	May 25, 2016
Warrant One [Member]
Date Granted	Jun. 12, 2012
Number Of Warrant Outstanding	150,000
Exercise price	$ 1
Expiration Date	Jun. 12, 2016
Warrant Two [Member]
Date Granted	Jun. 26, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1
Expiration Date	Jun. 26, 2016
Warrant Three [Member]
Date Granted	Jan. 1, 2012
Number Of Warrant Outstanding	500,000
Exercise price	$ 0.01
Expiration Date	Jan. 1, 2016

Fair Value Measurements and D36

Fair Value Measurements and Derivative Liabiliity (Details)	Feb. 29, 2016USD ($)
LIABILITIES
Derivative liability - February 29, 2016	$ 3,516,450
Derivative liability - May 31, 2015	$ 2,564,280
Level 1 [Member]
LIABILITIES
Derivative liability - February 29, 2016
Derivative liability - May 31, 2015
Level 2 [Member]
LIABILITIES
Derivative liability - February 29, 2016
Derivative liability - May 31, 2015
Level 3 [Member]
LIABILITIES
Derivative liability - February 29, 2016	$ 3,516,450
Derivative liability - May 31, 2015	$ 2,564,280

Fair Value Measurements and D37

Fair Value Measurements and Derivative Liabiliity (Details Narrative) - USD ($)	9 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Fair Value Measurements And Derivative Liabiliity Details Narrative
Convertible note agreements	$ 144,375	$ 180,829